Exploring Cryoglobulinemia's Clinical Odyssey: A Case Series

ABSTRACT Cryoglobulinemia (CG) encompasses disorders in which immunoglobulins precipitate at low temperatures. According to Brouet's classification, Type I CG is linked to plasma cell disorders, while mixed CG (Types II and III) is associated with autoimmune conditions, infections (notably hepa...

Full description

Saved in:
Bibliographic Details
Main Authors: Shivangini Duggal, Lakshmi Vaishnavi Prasanna Kattamuri, Michel Toutoungy, Eder Luna Ceron, Madhumita Rondla, Angelica Lehker
Format: Article
Language:English
Published: Wiley 2025-04-01
Series:eJHaem
Subjects:
Online Access:https://doi.org/10.1002/jha2.70029
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850155463877853184
author Shivangini Duggal
Lakshmi Vaishnavi Prasanna Kattamuri
Michel Toutoungy
Eder Luna Ceron
Madhumita Rondla
Angelica Lehker
author_facet Shivangini Duggal
Lakshmi Vaishnavi Prasanna Kattamuri
Michel Toutoungy
Eder Luna Ceron
Madhumita Rondla
Angelica Lehker
author_sort Shivangini Duggal
collection DOAJ
description ABSTRACT Cryoglobulinemia (CG) encompasses disorders in which immunoglobulins precipitate at low temperatures. According to Brouet's classification, Type I CG is linked to plasma cell disorders, while mixed CG (Types II and III) is associated with autoimmune conditions, infections (notably hepatitis C virus [HCV]), and lymphoproliferative disorders. Each type presents distinct symptoms, with Type I often causing severe vasomotor symptoms and Types II and III involving systemic features like purpura, Raynaud's phenomenon, and renal involvement. This case series presents three CG cases, illustrating diverse etiologies and presentations. Case 1 discusses CG in metastatic colon cancer with Staphylococcus aureus bacteremia, highlighting infection‐triggered CG. Case 2 covers HCV‐related mixed CG, emphasizing antiviral therapy's role. Case 3 describes a CG flare after rituximab therapy, managed with steroids. These cases emphasize a multidisciplinary approach and individualized management to address CG's complexity and improve patient outcomes. Clinical Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.
format Article
id doaj-art-e6ff467e37254f9bbc68e289353373b4
institution OA Journals
issn 2688-6146
language English
publishDate 2025-04-01
publisher Wiley
record_format Article
series eJHaem
spelling doaj-art-e6ff467e37254f9bbc68e289353373b42025-08-20T02:24:54ZengWileyeJHaem2688-61462025-04-0162n/an/a10.1002/jha2.70029Exploring Cryoglobulinemia's Clinical Odyssey: A Case SeriesShivangini Duggal0Lakshmi Vaishnavi Prasanna Kattamuri1Michel Toutoungy2Eder Luna Ceron3Madhumita Rondla4Angelica Lehker5Department of Internal Medicine Texas Tech Health Sciences Center El Paso Texas USADepartment of Internal Medicine Texas Tech Health Sciences Center El Paso Texas USAPaul L. Foster School of Medicine Texas Tech Health Sciences Center El Paso Texas USADepartment of Internal Medicine Texas Tech Health Sciences Center El Paso Texas USADepartment of Internal Medicine Texas Tech Health Sciences Center El Paso Texas USADepartment of Internal Medicine Texas Tech Health Sciences Center El Paso Texas USAABSTRACT Cryoglobulinemia (CG) encompasses disorders in which immunoglobulins precipitate at low temperatures. According to Brouet's classification, Type I CG is linked to plasma cell disorders, while mixed CG (Types II and III) is associated with autoimmune conditions, infections (notably hepatitis C virus [HCV]), and lymphoproliferative disorders. Each type presents distinct symptoms, with Type I often causing severe vasomotor symptoms and Types II and III involving systemic features like purpura, Raynaud's phenomenon, and renal involvement. This case series presents three CG cases, illustrating diverse etiologies and presentations. Case 1 discusses CG in metastatic colon cancer with Staphylococcus aureus bacteremia, highlighting infection‐triggered CG. Case 2 covers HCV‐related mixed CG, emphasizing antiviral therapy's role. Case 3 describes a CG flare after rituximab therapy, managed with steroids. These cases emphasize a multidisciplinary approach and individualized management to address CG's complexity and improve patient outcomes. Clinical Trial Registration: The authors have confirmed clinical trial registration is not needed for this submission.https://doi.org/10.1002/jha2.70029case seriescolon cancercryoglobulinemiahepatitis Cmonoclonal gammopathy of undetermined significance
spellingShingle Shivangini Duggal
Lakshmi Vaishnavi Prasanna Kattamuri
Michel Toutoungy
Eder Luna Ceron
Madhumita Rondla
Angelica Lehker
Exploring Cryoglobulinemia's Clinical Odyssey: A Case Series
eJHaem
case series
colon cancer
cryoglobulinemia
hepatitis C
monoclonal gammopathy of undetermined significance
title Exploring Cryoglobulinemia's Clinical Odyssey: A Case Series
title_full Exploring Cryoglobulinemia's Clinical Odyssey: A Case Series
title_fullStr Exploring Cryoglobulinemia's Clinical Odyssey: A Case Series
title_full_unstemmed Exploring Cryoglobulinemia's Clinical Odyssey: A Case Series
title_short Exploring Cryoglobulinemia's Clinical Odyssey: A Case Series
title_sort exploring cryoglobulinemia s clinical odyssey a case series
topic case series
colon cancer
cryoglobulinemia
hepatitis C
monoclonal gammopathy of undetermined significance
url https://doi.org/10.1002/jha2.70029
work_keys_str_mv AT shivanginiduggal exploringcryoglobulinemiasclinicalodysseyacaseseries
AT lakshmivaishnaviprasannakattamuri exploringcryoglobulinemiasclinicalodysseyacaseseries
AT micheltoutoungy exploringcryoglobulinemiasclinicalodysseyacaseseries
AT ederlunaceron exploringcryoglobulinemiasclinicalodysseyacaseseries
AT madhumitarondla exploringcryoglobulinemiasclinicalodysseyacaseseries
AT angelicalehker exploringcryoglobulinemiasclinicalodysseyacaseseries